Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Consultation record

Submissions accepted — page 19

The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.

Submissions

681 documents · page 19 of 23

Table 1. Submissions with this disposition, on this page.

ReferenceConsultationRespondentPoint raised
DRAFT-AGGREGATES-S/005Draft standard CEI-MS-11: Determination of aggregate content by…Dr Gervase CrickhowellA conformance claim is not defined and will be made loosely
DRAFT-AGGREGATES-S/004Draft standard CEI-MS-11: Determination of aggregate content by…Dr Rurik Haverkamp-DialloTerms are used in senses that differ from established pharmacopoeial usage
DRAFT-AGGREGATES-S/002Draft standard CEI-MS-11: Determination of aggregate content by…Ignatius ErlingssonQuantitative claims are reproduced without the method that produced them
DRAFT-AGGREGATES-S/001Draft standard CEI-MS-11: Determination of aggregate content by…Dr Rosalind Grünbaum-SowandeA determination does not record the version of the standard it was made under
DRAFT-AGGREGATES-S/007Draft standard CEI-MS-11: Determination of aggregate content by…Dr Adaeze Dunmore-EkpoThe standard does not say what to do with a result outside the expected range
DRAFT-RESIDUAL-SOL/008Draft standard CEI-MS-12: Residual solvent determination by static…Dr Wilhelmina ErlingssonQuantitative claims are reproduced without the method that produced them
DRAFT-RESIDUAL-SOL/005Draft standard CEI-MS-12: Residual solvent determination by static…Dr Rosalind Grünbaum-SowandeThe limitations section states what the method cannot do but not what a reader will wrongly conclude
DRAFT-RESIDUAL-SOL/011Draft standard CEI-MS-12: Residual solvent determination by static…Brigitta Grünbaum-SowandeTerms are used in senses that differ from established pharmacopoeial usage
DRAFT-RESIDUAL-SOL/010Draft standard CEI-MS-12: Residual solvent determination by static…Rosalind PetrossianNothing requires the report to state who performed the determination
DRAFT-RESIDUAL-SOL/015Draft standard CEI-MS-12: Residual solvent determination by static…Ivo MountstephenThe standard does not state that a determination on one unit says nothing about the batch
DRAFT-RESIDUAL-SOL/007Draft standard CEI-MS-12: Residual solvent determination by static…Dr Adaeze Dunmore-EkpoA determination does not record the version of the standard it was made under
DRAFT-RESIDUAL-SOL/013Draft standard CEI-MS-12: Residual solvent determination by static…Vasilisa Sandringham-AduRounding conventions are not stated and change the reported result
DRAFT-RESIDUAL-SOL/003Draft standard CEI-MS-12: Residual solvent determination by static…Dr Oisín Marchetti-BasseyThe standard would be applied more consistently with a worked example
DRAFT-STABILITY-IN/006Draft standard CEI-MS-13: Development and validation of a…Xiomara Fairweather-DuruThe same concept is given three different names in one document
DRAFT-STABILITY-IN/009Draft standard CEI-MS-13: Development and validation of a…Dr Adaeze Dunmore-EkpoThe limitations section states what the method cannot do but not what a reader will wrongly conclude
DRAFT-STABILITY-IN/007Draft standard CEI-MS-13: Development and validation of a…Dr Ndidi Ravensworth-IlungaThe draft prescribes a procedure where it should state performance
DRAFT-STABILITY-IN/004Draft standard CEI-MS-13: Development and validation of a…Dr Rurik Underhill-OkaforRounding conventions are not stated and change the reported result
DRAFT-THIRD-PARTY-/001Draft standard CEI-MS-15: Protocol for independent third-party…Dr Yolanda Norrington-BhattNothing requires the report to state who performed the determination
DRAFT-THIRD-PARTY-/008Draft standard CEI-MS-15: Protocol for independent third-party…Dr Thaddeus Isaksen-BalogunA determination does not record the version of the standard it was made under
DRAFT-THIRD-PARTY-/007Draft standard CEI-MS-15: Protocol for independent third-party…Dr Melisande Kirkpatrick-OlaThe search date is not on the face of the document
DRAFT-THIRD-PARTY-/009Draft standard CEI-MS-15: Protocol for independent third-party…Dr Gaspard WintringhamThe standard assumes a reference standard of known assigned content
DRAFT-THIRD-PARTY-/012Draft standard CEI-MS-15: Protocol for independent third-party…Professor Chukwuemeka Rasmussen-AdeyemiThe same concept is given three different names in one document
DRAFT-THIRD-PARTY-/005Draft standard CEI-MS-15: Protocol for independent third-party…Dr Gervase AbergavennyTerms are used in senses that differ from established pharmacopoeial usage
DRAFT-THIRD-PARTY-/004Draft standard CEI-MS-15: Protocol for independent third-party…Dr Georgiana ZimmerthalA conformance claim is not defined and will be made loosely
DRAFT-APPEARANCE-S/005Draft standard CEI-MS-09: Assessment of appearance, cake integrity…Dr Beatrijs HazelriggNothing requires the report to state who performed the determination
DRAFT-APPEARANCE-S/010Draft standard CEI-MS-09: Assessment of appearance, cake integrity…Dr Hyacinth Drakeford-AmadiThe limitations section states what the method cannot do but not what a reader will wrongly conclude
DRAFT-APPEARANCE-S/013Draft standard CEI-MS-09: Assessment of appearance, cake integrity…Dr Vasilisa ImmelmannTerms are used in senses that differ from established pharmacopoeial usage
DRAFT-APPEARANCE-S/012Draft standard CEI-MS-09: Assessment of appearance, cake integrity…Dr Bertrand Steenkamp-FerreiraThe scope does not say which materials the standard excludes
DRAFT-APPEARANCE-S/009Draft standard CEI-MS-09: Assessment of appearance, cake integrity…Professor Bartolomeu Nkosi-LindegaardThe matrix interferes with the determination and no control is required
DRAFT-APPEARANCE-S/003Draft standard CEI-MS-09: Assessment of appearance, cake integrity…Hortensia HollingworthThe search date is not on the face of the document

page 19 of 23

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.